{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:36:02Z","timestamp":1783568162196,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health Research Board Ireland","award":["SS-2019-010"],"award-info":[{"award-number":["SS-2019-010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Fam Pract"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Uncontrolled blood pressure (BP) is an important modifiable risk factor for recurrent stroke. Secondary prevention measures when implemented can reduce stroke re-occurrence by 80%. However, hypertension control rates remain sub-optimal, and little data is available from primary care where most management occurs.<\/jats:p>\n<jats:p>The aim of this study was to describe BP control in primary care-based patients with a previous stroke or transient ischaemic attack (TIA) in Ireland, and to concurrently examine antihypertensive medication-dosing.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Study participants most recent office-based BP reading was compared with the NICE (NG136) and European Society of Hypertension\/ European Society of Cardiology (ESH\/ESC 2013) goal of BP &lt;\u2009140\/90\u2009mmHg. Optimal anti-hypertensive medication dosing was determined by benchmarking prescribed doses for each drug with the World Health Organisation-Defined Daily Dosing (WHO-DDD) recommendations.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We identified 328 patients with a previous stroke or TIA in 10 practices. Blood pressure was controlled in almost two thirds of patients when measured against the ESH\/ESC and NICE guidelines (63.1%, <jats:italic>n<\/jats:italic>\u2009=\u2009207). Of those with BP \u2265140\/90 (<jats:italic>n<\/jats:italic>\u2009=\u2009116), just under half (<jats:italic>n<\/jats:italic>\u2009=\u200944, 47.3%) were adequately dosed in all anti-hypertensive medications when compared with the WHO-DDD recommendations.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Blood pressure control in patients post stroke\/TIA appears sub-optimal in over one third of patients. A comparison of drug doses with WHO-DDD recommendations suggests that 47% of patients may benefit from drug-dose improvements. Further work is required to assess how best to manage blood pressure in patients with a previous stroke or TIA in Primary Care, as most consultations for hypertension take place in this setting.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12875-020-01211-z","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T19:02:42Z","timestamp":1594407762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Blood pressure control in patients with a previous stroke\/transient ischaemic attack in primary care in Ireland: a cross sectional study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4539-3982","authenticated-orcid":false,"given":"R\u00f3is\u00edn","family":"Doogue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noirin","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam G.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"1211_CR1","unstructured":"Wilkins E, Wilson L, Wickramasinghe K, Bhatnagar P, Leal J, Luengo-Fernandez R, et al. European cardiovascular disease statistics 2017. Brussels: European Heart Network; 2017. http:\/\/www.ehnheart.org\/images\/CVD-statistics-report-August-2017.pdf."},{"issue":"2","key":"1211_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/2396987318816136","volume":"4","author":"A Webb","year":"2019","unstructured":"Webb A, Heldner M, Aguiar de Sousa D, Sandset E, Randall G, Bejot Y, et al. Availability of secondary prevention services after stroke in Europe: an ESO\/SAFE survey of national scientific societies and stroke experts. Eur Stroke J. 2019;4(2):110\u20138.","journal-title":"Eur Stroke J"},{"issue":"4","key":"1211_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/2396987318808719","volume":"3","author":"B Norrving","year":"2018","unstructured":"Norrving B, Barrick J, Davalos A, Dichgans M, Cordonnier C, Guekht A, et al. Action plan for stroke in Europe 2018-2030. Eur Stroke J. 2018;3(4):309\u201336.","journal-title":"Eur Stroke J"},{"issue":"23","key":"1211_CR4","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1056\/NEJMoa1802712","volume":"378","author":"P Amarenco","year":"2018","unstructured":"Amarenco P, Lavall\u00e9e PC, Monteiro Tavares L, Labreuche J, Albers GW, Abboud H, et al. Five-year risk of stroke after TIA or minor ischemic stroke. N Engl J Med. 2018;378(23):2182\u201390.","journal-title":"N Engl J Med"},{"key":"1211_CR5","volume-title":"The burden of stroke in Europe","author":"E Stevens","year":"2017","unstructured":"Stevens E, Emmett E, Wang Y, McKevitt C, Wolfe C. The burden of stroke in Europe. London: Stroke Alliance for Europe; 2017."},{"issue":"10046","key":"1211_CR6","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","volume":"388","author":"MJ O'Donnell","year":"2016","unstructured":"O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761\u201375.","journal-title":"Lancet."},{"key":"1211_CR7","doi-asserted-by":"publisher","first-page":"b1665","DOI":"10.1136\/bmj.b1665","volume":"338","author":"MR Law","year":"2009","unstructured":"Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.","journal-title":"BMJ."},{"issue":"10199","key":"1211_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(19)31145-6","volume":"394","author":"B Zhou","year":"2019","unstructured":"Zhou B, Danaei G, Stevens GA, Bixby H, Taddei C, Carrillo-Larco RM, et al. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394(10199):639\u201351.","journal-title":"Lancet"},{"key":"1211_CR9","doi-asserted-by":"publisher","first-page":"212560","DOI":"10.7573\/dic.212560","volume":"8","author":"MA Hameed","year":"2019","unstructured":"Hameed MA, Dasgupta I. Medication adherence and treatment-resistant hypertension: a review. Drugs Context. 2019;8:212560.","journal-title":"Drugs Context"},{"issue":"8","key":"1211_CR10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1751-7176.2008.08329.x","volume":"10","author":"G Ogedegbe","year":"2008","unstructured":"Ogedegbe G. Barriers to optimal hypertension control. J Clin Hypertens. 2008;10(8):644\u20136.","journal-title":"J Clin Hypertens"},{"issue":"33","key":"1211_CR11","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"671","key":"1211_CR12","doi-asserted-by":"publisher","first-page":"e394","DOI":"10.3399\/bjgp18X696221","volume":"68","author":"P Hayes","year":"2018","unstructured":"Hayes P, Casey M, Glynn LG, Molloy GJ, Durand H, O'Brien E, et al. Prevalence of treatment-resistant hypertension after considering pseudo-resistance and morbidity: a cross-sectional study in Irish primary care. Br J Gen Pract. 2018;68(671):e394\u2013400.","journal-title":"Br J Gen Pract"},{"issue":"19","key":"1211_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and Management of High Blood Pressure in adults. J Am Coll Cardiol. 2018;71(19):e127.","journal-title":"J Am Coll Cardiol"},{"issue":"28","key":"1211_CR14","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159\u2013219.","journal-title":"Eur Heart J"},{"key":"1211_CR15","unstructured":"NICE. Hypertension in adults: diagnosis and management (CG 127). London: National Institute for Health and Care Excellence; 2011. https:\/\/www.nice.org.uk\/guidance\/cg127."},{"key":"1211_CR16","unstructured":"NICE. Hypertension in adults: diagnosis and management: NICE guideline [NG136] National Institute for Health and Care Excellence; 2019. Available from: https:\/\/www.nice.org.uk\/guidance\/ng136."},{"key":"1211_CR17","unstructured":"Government of Ireland. Health in Ireland Key Trends 2018. Dublin; 2018. Available from: https:\/\/health.gov.ie\/wp-content\/uploads\/2018\/12\/Key-Trends-2018.pdf."},{"key":"1211_CR18","volume-title":"Medical card application process","author":"Health Service Executive","year":"2018","unstructured":"Health Service Executive. Medical card application process 2018. Available from: https:\/\/www2.hse.ie\/services\/medical-cards\/medical-card-application-process\/how-much-you-can-earn-and-still-qualify-for-a-medical-card.html."},{"key":"1211_CR19","volume-title":"Primary Care Reimbursement Service. Statistical Analysis of Claims and Payments 2018","author":"Health Service Executive","year":"2018","unstructured":"Health Service Executive. Primary Care Reimbursement Service. Statistical Analysis of Claims and Payments 2018. Dublin: Health Service Executive, Primary Care Reimbursement Service; 2018."},{"issue":"1","key":"1211_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12875-020-1100-y","volume":"21","author":"A O'Regan","year":"2020","unstructured":"O'Regan A, Hayes P, O'Connor R, Casey M, O'Dwyer P, Culhane A, et al. The University of Limerick Education and research network for general practice (ULEARN-GP): practice characteristics and general practitioner perspectives. BMC Fam Pract. 2020;21(1):25.","journal-title":"BMC Fam Pract"},{"key":"1211_CR21","volume-title":"Structure of General Practice in Ireland 1982 \u2014 2015","author":"M O'Kelly","year":"2016","unstructured":"O'Kelly M, Teljeur C, O\u2019Kelly F, Ni Sh\u00failleabh\u00e1in A, O\u2019Dowd T. Structure of General Practice in Ireland 1982 \u2014 2015. Dublin: Department of Public Health and Primary Care, Trinity College Centre for Health Sciences; 2016."},{"key":"1211_CR22","volume-title":"ICD-10: international statistical classification of diseases and related health problems: tenth revision","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. ICD-10: international statistical classification of diseases and related health problems: tenth revision. 2004."},{"key":"1211_CR23","volume-title":"Academic Associations of General Practitioners\/Family Physicians,. ICPC-2-R. International Classification of Primary Care. Revised Second Edition","author":"World Organization of National Colleges A","year":"2005","unstructured":"World Organization of National Colleges A. Academic Associations of General Practitioners\/Family Physicians,. ICPC-2-R. International Classification of Primary Care. Revised Second Edition. USA: Oxford University Press; 2005."},{"key":"1211_CR24","volume-title":"Good practice points on cardiovascular disease prevention","author":"Irish College of General Practitioners","year":"2020","unstructured":"Irish College of General Practitioners. Good practice points on cardiovascular disease prevention. Dublin: ICGP; 2020."},{"key":"1211_CR25","volume-title":"Council for Stroke. National Clinical Guidelines and Recommendations for the Care of People with Stroke and Transient Ischaemic Attack","author":"Irish Heart Foundation","year":"2010","unstructured":"Irish Heart Foundation. Council for Stroke. National Clinical Guidelines and Recommendations for the Care of People with Stroke and Transient Ischaemic Attack. Dublin: Irish Heart Foundation; 2010."},{"key":"1211_CR26","volume-title":"Chronic kidney disease in adults: assessment and management, CG182","author":"NICE","year":"2014","unstructured":"NICE. Chronic kidney disease in adults: assessment and management, CG182 2014. Available from: https:\/\/www.nice.org.uk\/guidance\/cg182."},{"key":"1211_CR27","volume-title":"BNF 77: march- September 2019","author":"BMJ Group and Pharmaceutical Press","year":"2019","unstructured":"BMJ Group and Pharmaceutical Press. BNF 77: march- September 2019. London: British Medical Association, Royal Pharmaceutical Society of Great Britain; 2019."},{"key":"1211_CR28","volume-title":"World Health Organisation collaborating centre for drug statistics methodology. ATC\/DDD","author":"WHO","year":"2019","unstructured":"WHO. World Health Organisation collaborating centre for drug statistics methodology. ATC\/DDD 2019. Available from: https:\/\/www.whocc.no\/atc_ddd_index\/."},{"issue":"4","key":"1211_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1161\/HYPERTENSIONAHA.113.01448","volume":"62","author":"BM Egan","year":"2013","unstructured":"Egan BM, Zhao Y, Li J, Brzezinski WA, Todoran TM, Brook RD, et al. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network. Hypertension. 2013;62(4):691\u20137.","journal-title":"Hypertension"},{"key":"1211_CR30","volume-title":"IBM SPSS Statistics for Windows. Version 26 ed","author":"IBM","year":"2018","unstructured":"IBM. IBM SPSS Statistics for Windows. Version 26 ed. Aramonk: IBM Corp.; 2018."},{"issue":"1","key":"1211_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12875-018-0872-9","volume":"19","author":"RA Pedersen","year":"2018","unstructured":"Pedersen RA, Petursson H, Hetlevik I. Stroke follow-up in primary care: a prospective cohort study on guideline adherence. BMC Fam Pract. 2018;19(1):179.","journal-title":"BMC Fam Pract"},{"issue":"3","key":"1211_CR32","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/ageing\/afr141","volume":"41","author":"S Smith","year":"2012","unstructured":"Smith S, Horgan F, Sexton E, Cowman S, Hickey A, Kelly P, et al. The cost of stroke and transient ischaemic attack in Ireland: a prevalence-based estimate. Age Ageing. 2012;41(3):332\u20138.","journal-title":"Age Ageing"},{"key":"1211_CR33","volume-title":"Cost of Stroke in Ireland. Estimating the annual economic cost of stroke and transient ischaemic attack (TIA) in Ireland","author":"S Smith","year":"2010","unstructured":"Smith S, Horgan F, Sexton E, Wiley M. Cost of Stroke in Ireland. Estimating the annual economic cost of stroke and transient ischaemic attack (TIA) in Ireland. Dublin: Economic and Social Research Institute (ESRI) and the Royal College of Surgeons in Ireland (RCSI) for the Irish Heart Foundation; 2010."},{"issue":"1","key":"1211_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/2396987317746516","volume":"3","author":"X-M Xu","year":"2018","unstructured":"Xu X-M, Vestesson E, Paley L, Desikan A, Wonderling D, Hoffman A, et al. The economic burden of stroke care in England, Wales and Northern Ireland: using a national stroke register to estimate and report patient-level health economic outcomes in stroke. Eur Stroke J. 2018;3(1):82\u201391.","journal-title":"Eur Stroke J"},{"issue":"22","key":"1211_CR35","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"SPRINT Research Group","year":"2015","unstructured":"SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103\u201316.","journal-title":"N Engl J Med"},{"issue":"42","key":"1211_CR36","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1093\/eurheartj\/ehz681","volume":"40","author":"T McCormack","year":"2019","unstructured":"McCormack T, Boffa RJ, Jones NR, Carville S, McManus RJ. The 2018 ESC\/ESH hypertension guideline and the 2019 NICE hypertension guideline, how and why they differ. Eur Heart J. 2019;40(42):3456\u20138.","journal-title":"Eur Heart J"},{"issue":"9891","key":"1211_CR37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","volume":"382","author":"OR Benavente","year":"2013","unstructured":"Group SPSS, Benavente OR, Coffey CS, Conwit R, Hart RG, McClure LA, et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013;382(9891):507\u201315.","journal-title":"Lancet"},{"issue":"3","key":"1211_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40256-013-0025-4","volume":"13","author":"V Gil-Guillen","year":"2013","unstructured":"Gil-Guillen V, Orozco-Beltran D, Carratala-Munuera C, Marquez-Contreras E, Durazo-Arvizu R, Cooper R, et al. Clinical inertia in poorly controlled elderly hypertensive patients: a cross-sectional study in Spanish physicians to ascertain reasons for not intensifying treatment. Am J Cardiovasc Drugs. 2013;13(3):213\u20139.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"5","key":"1211_CR39","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/jama.2019.9811","volume":"322","author":"W-Y Yang","year":"2019","unstructured":"Yang W-Y, Melgarejo JD, Thijs L, Zhang Z-Y, Boggia J, Wei F-F, et al. Association of Office and Ambulatory Blood Pressure with Mortality and cardiovascular OutcomesAssociation of office and ambulatory blood pressure with mortality and CV OutcomesAssociation of office and ambulatory blood pressure with mortality and CV outcomes. JAMA. 2019;322(5):409\u201320.","journal-title":"JAMA"},{"key":"1211_CR40","volume-title":"National Stroke Audit 2015. Report","author":"P McElwaine","year":"2015","unstructured":"McElwaine P, McCormack J, Harbison J. National Stroke Audit 2015. Report; 2015."},{"key":"1211_CR41","volume-title":"National Stroke Register Report 2018","author":"Health Service Executive","year":"2019","unstructured":"Health Service Executive. National Stroke Register Report 2018. Dublin: Programme NS; 2019."},{"key":"1211_CR42","volume-title":"Terms of agreement between the Department of Health, the HSE and the IMO regarding GP contractual reform and service development","author":"Executive HS","year":"2019","unstructured":"Executive HS. Terms of agreement between the Department of Health, the HSE and the IMO regarding GP contractual reform and service development. Dublin: Health Services Executive (HSE), Department of Health; 2019."},{"issue":"2","key":"1211_CR43","doi-asserted-by":"publisher","first-page":"bjgpopen20X1010","DOI":"10.3399\/bjgpopen20X101021","volume":"4","author":"R O'Connor","year":"2020","unstructured":"O'Connor R, O'Driscoll R, O'Doherty J, Hannigan A, O'Neill A, Teljeur C, et al. The effect of \u2018paying for performance\u2019 on the management of type 2 diabetes mellitus: a cross-sectional observational study. BJGP Open. 2020;4(2):bjgpopen20X101021.","journal-title":"BJGP Open"},{"issue":"2","key":"1211_CR44","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.aogh.2016.02.005","volume":"82","author":"JP Sheppard","year":"2016","unstructured":"Sheppard JP, Schwartz CL, Tucker KL, McManus RJ. Modern management and diagnosis of hypertension in the United Kingdom: home care and self-care. Ann Glob Health. 2016;82(2):274\u201387.","journal-title":"Ann Glob Health"}],"container-title":["BMC Family Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-020-01211-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-020-01211-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-020-01211-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T23:21:14Z","timestamp":1625872874000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-020-01211-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1211"],"URL":"https:\/\/doi.org\/10.1186\/s12875-020-01211-z","relation":{},"ISSN":["1471-2296"],"issn-type":[{"value":"1471-2296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"assertion":[{"value":"24 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was granted by the University Hospital Limerick Ethics Committee (Ref 077\/19).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}